Presentation of Q2 and first half year 2011 results 12 August, 08:30 AM CET
(Thomson Reuters ONE) -
4 August 2011, Lysaker, Norway: Pronova BioPharma ASA will publish the group's
second quarter and first half year 2011 results on Friday 12 August 2011.
Morten Jurs, CEO, and Synne H. Røine, CFO, will give a presentation of the
results at Hotel Continental, Stortingsgaten 24/26, Oslo at 08:30 AM CET.
Breakfast will be served from 08:00 AM CET. Participants are asked to register
at www.pronova.com.
The presentation will also be web-casted live (video) over the Internet and can
be accessed from www.pronova.com where questions can be submitted live during
the presentation. The company will host a telephone conference to listen live to
the presentation.
Please dial the following numbers:
Connection of the participants (5 minutes before the conference)
International Toll Number: UK: + 44 2071086205
International Toll Number: SE: + 46 8-506 853 35
International Toll Number: NO: + 47 21 01 09 27
No conference ID is required.
For further information, please contact:
Hamed Brodersen, Vice President Investor Relations (IR) and Communications:
+47 40 46 81 10.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
[HUG#1536199]
Unternehmensinformation / Kurzprofil:
Datum: 04.08.2011 - 10:14 Uhr
Sprache: Deutsch
News-ID 56984
Anzahl Zeichen: 1992
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 179 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Presentation of Q2 and first half year 2011 results 12 August, 08:30 AM CET"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
